Description
WHO recommended Artemisinin Combination Therapy
Contains Artesunate and Amodiaquine
Residual protection as a result of half-life of over 30 days due to the Amodiaquine component
?Vanilla flavoured children formulation
Single unit granular doses for children
No degradation due to hydrolysis
Convenient 3 days dosage regimen
Reviews
There are no reviews yet.